REGINA, SK – A research project at the University of Regina that hopes to overcome the challengse of antibiotic resistance facing health care professionals and patients is getting new funding from the Federal Government.
As part of his research project, Dr. Mohan Babu, an assistant professor at the University of Regina, plans to use the latest in proteomics and genomics technologies to screen the genes of the bacterium Escherichia coli to understand how the interaction between genes contributes to drug resistance. The hope is that this work will produce knowledge to guide the development of new therapeutic strategies to address the challenge of antibiotic resistance.
Antibiotic resistance happens when bacteria that cause illness become resistant to the antibiotic drugs used to treat them. The threat of antibiotic resistance is that infections such as pneumonia become untreatable. This situation has created an urgent demand for new treatments for bacterial infections.
The project will be supported by a grant of $1,123,815 over five years from the Canadian Institutes of Health Research (CIHR). The project is one of 491 projects funded in CIHR’s 2016 Project Grant competition.
“This award has come at the right moment,” says Dr. Babu adding that his team has accomplished a lot in the area of bacterial genetics and systems biology. “We now have the financial capability and innovative strategies to take the next steps toward identifying new drug targets. This means we are closer to coming up with new broad spectrum drugs that will kill bacterial infections, such as E. coli,” he said.